We are live on ! Find out more
B

Braidwell Portfolio holdings

AUM $3B
1-Year Est. Return 46.72%
This Fund
S&P 500
This Quarter Est. Return
+4.66%
1 Year Est. Return
+46.72%
3 Year Est. Return
+56.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.98B
AUM Growth
–
Cap. Flow
+$1.68B
Cap. Flow %
56.29%
Top 10 Hldgs %
33.01%
Holding
88
New
63
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
GKOS icon
Glaukos
GKOS
+$82M
2
BIIB icon
Biogen
BIIB
+$71.3M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$71.3M
4
NTRA icon
Natera
NTRA
+$66.8M
5
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$61.1M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 56.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NKTX icon
51
Nkarta
NKTX
$162M
$9.14M 0.31%
+1,525,800
New +$15.4M
CMPX icon
52
Compass Therapeutics
CMPX
$373M
$9.13M 0.31%
+1,814,266
New +$7.24M
DYN icon
53
Dyne Therapeutics
DYN
$4.04B
$8.73M 0.29%
+753,145
New +$8.71M
NUVB icon
54
Nuvation Bio
NUVB
$2.24B
$7.92M 0.27%
+4,122,900
New +$8.34M
ALLK
55
DELISTED
Allakos
ALLK
$7.75M 0.26%
+920,304
New +$6.39M
ALEC icon
56
Alector
ALEC
$164M
$6.69M 0.22%
+725,024
New +$6.32M
KOD icon
57
Kodiak Sciences
KOD
$2.59B
$6.55M 0.22%
+914,209
New +$6.56M
FUSN
58
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$6.3M 0.21%
+2,000,000
New +$4.98M
MIST icon
59
Milestone Pharmaceuticals
MIST
$144M
$4.61M 0.15%
+1,164,849
New +$6.13M
MLTX icon
60
MoonLake Immunotherapeutics
MLTX
$1.59B
$4M 0.13%
+381,120
New +$3.39M
ALXO icon
61
ALX Oncology
ALXO
$273M
$2.91M 0.1%
+258,280
New +$2.9M
NKTR icon
62
Nektar Therapeutics
NKTR
$2.39B
$1.4M 0.05%
+41,352
New +$2M
ITOS
63
DELISTED
iTeos Therapeutics
ITOS
$1.4M 0.05%
+71,585
New +$1.4M
1 2
3

Similar funds

NC
NZS Capital Denver, Colorado $3B AUM 21.29% 1-Year Est. Return
SGI
Swan Global Investments Durango, Colorado $3B AUM 15.66% 1-Year Est. Return
SP
SurgoCap Partners New York $2.99B AUM 39.34% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VVP
Venture Visionary Partners Sylvania, Ohio $3B AUM 24.41% 1-Year Est. Return
ROTUOC
Regents of the University of California Oakland, California $3.01B AUM 11.91% 1-Year Est. Return
PHAM
Pacific Heights Asset Management San Francisco, California $2.99B AUM 52.5% 1-Year Est. Return

Braidwell's Q4 2022 Portfolio in Review

Q4 2022 is the first quarter with a 13F filing on record for Braidwell, which disclosed 88 positions worth $2.98B. Its ten largest holdings account for 33% of the portfolio.

Its largest position is Glaukos: 1,661,851 shares worth $72.6M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets.

  • Braidwell's largest Q4 2022 buy was Glaukos: 1,661,851 shares worth $72.6M.
  • Braidwell's ten largest holdings make up 33% of its $2.98B portfolio in Q4 2022.
  • Braidwell disclosed 88 positions in Q4 2022, its first 13F filing on record.

Based on Braidwell's 13F filing for Q4 2022, filed 14 Feb 2023.